Abstract
Diabetic macular edema (DME) is still one of the main causes of visual impairment. Repeated intravitreal injections of ranibizumab are considered the gold standard treatment, but the efficacy in patients with prominent cystic characteristics remains uncertain. In diabetic retinas, the identification of both antero-posterior and, particularly, tangential tractions is crucial to prevent misdiagnosis of tractional and refractory DME, and therefore to prevent poor treatment outcomes. The treatment of tractional DME with anti-VEGF injections could be poorly effective due to the influence of a tractional force. Pars plana vitrectomy (PPV) is a surgical procedure that has been widely used in the treatment of diffuse and refractory DME. Anatomical improvement, although stable and immediate, did not result in visual improvement. PPV with internal limiting membrane (ILM) peeling for the treatment of non-tractional DME in patients with prominent cysts (> 390 μm) causes subfoveal atrophy, defined as “floor effect”. Epiretinal tangential forces and intraretinal change evaluation by SD-OCT of non-tractional DME are essential for determining appropriate management.
Similar content being viewed by others
References
Ciulla TA, Amador AG, Zinman B (2003) Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26:2653–2664
Early Treatment Diabetic Retinopathy Study research group (1985) Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol (Chicago, Ill 1960) 103:1796–1806
Dowler JGF (2003) Laser management of diabetic retinopathy. J R Soc Med 96:277–279
Ferrara N, Damico L, Shams N et al (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859–870. https://doi.org/10.1097/01.iae.0000242842.14624.e7
Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study. Ophthalmology 118:615–625. https://doi.org/10.1016/j.ophtha.2011.01.031
Nguyen QD, Brown DM, Marcus DM et al (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119:789–801. https://doi.org/10.1016/j.ophtha.2011.12.039
Diabetic Retinopathy Clinical Research Network MJ, Elman MJ, Qin H, et al (2012) Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 119:2312–2318. https://doi.org/10.1016/j.ophtha.2012.08.022
Do DV, Nguyen QD, Khwaja AA et al (2013) Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 131:139–145. https://doi.org/10.1001/2013.jamaophthalmol.91
Schmidt-Erfurth U, Lang GE, Holz FG et al (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121:1045–1053. https://doi.org/10.1016/j.ophtha.2013.11.041
Brown DM, Nguyen QD, Marcus DM et al (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120:2013–2022. https://doi.org/10.1016/j.ophtha.2013.02.034
Comyn O, Sivaprasad S, Peto T et al (2014) A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study). Am J Ophthalmol 157:960–970. https://doi.org/10.1016/j.ajo.2014.02.019
Browning DJ (2010) Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis). Trans Am Ophthalmol Soc 108:62–76
Massin P, Duguid G, Erginay A et al (2003) Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135:169–177
Sebag J (1987) Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225:89–93
Sebag J (2004) Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 242:690–698. https://doi.org/10.1007/s00417-004-0980-1
Lundquist O, Osterlin S (1994) Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol 232:71–74
Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol (Chicago, Ill 1960) 110:1472–1476
Stitt AW (2001) Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 85:746–753
Gella L, Raman R, Kulothungan V, Sharma T (2012) Prevalence of posterior vitreous detachment in the population with type II diabetes mellitus and its effect on diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study SN-DREAMS report no. 23. Jpn J Ophthalmol 56:262–267. https://doi.org/10.1007/s10384-012-0134-7
Duker JS, Kaiser PK, Binder S et al (2013) The international Vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611–2619. https://doi.org/10.1016/j.ophtha.2013.07.042
Sebag J (2008) Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 246:329–332. https://doi.org/10.1007/s00417-007-0743-x
Qiao H, Hisatomi T, Sonoda K-H et al (2005) The characterisation of hyalocytes: the origin, phenotype, and turnover. Br J Ophthalmol 89:513–517. https://doi.org/10.1136/bjo.2004.050658
Sebag J, Gupta P, Rosen RR et al (2007) Macular holes and macular pucker: the role of vitreoschisis as imaged by optical coherence tomography/scanning laser ophthalmoscopy. Trans Am Ophthalmol Soc 105:121–129 discusion 129–31
Romano MR, Vallejo-Garcia JL, Camesasca FI et al (2012) Vitreo-papillary adhesion as a prognostic factor in pseudo- and lamellar macular holes. Eye 26:810–815. https://doi.org/10.1038/eye.2012.43
Abe S, Yamamoto T, Kashiwagi Y et al (2013) Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema. Jpn J Ophthalmol 57:553–562. https://doi.org/10.1007/s10384-013-0275-3
Bringmann A, Wiedemann P (2009) Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol 247:865–883. https://doi.org/10.1007/s00417-009-1082-x
Bu S-C, Kuijer R, Li X-R et al (2014) Idiopathic epiretinal membrane. Retina 34:2317–2335. https://doi.org/10.1097/IAE.0000000000000349
Govetto A, Lalane RA, Sarraf D et al (2017) Insights into Epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am J Ophthalmol 175:99–113. https://doi.org/10.1016/j.ajo.2016.12.006
Erickson PA, Fisher SK, Guérin CJ et al (1987) Glial fibrillary acidic protein increases in Müller cells after retinal detachment. Exp Eye Res 44:37–48
Lewis GP, Fisher SK (2003) Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 230:263–290
Lewis GP, Guérin CJ, Anderson DH et al (1994) Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am J Ophthalmol 118:368–376
Rutka JT, Murakami M, Dirks PB et al (1997) Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87:420–430. https://doi.org/10.3171/jns.1997.87.3.0420
Charteris DG, Downie J, Aylward GW et al (2007) Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 245:93–100. https://doi.org/10.1007/s00417-006-0323-5
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239. https://doi.org/10.1056/NEJMra1005073
Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113:E2655–E2664. https://doi.org/10.1073/pnas.1522014113
Tien T, Zhang J, Muto T et al (2017) High glucose induces mitochondrial dysfunction in retinal Müller cells: implications for diabetic retinopathy. Invest Opthalmol Vis Sci 58:2915. https://doi.org/10.1167/iovs.16-21355
Zhang Z-H, Liu H-Y, Hernandez-Da Mota SE et al (2013) Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials. Am J Ophthalmol 156:106–115.e2. https://doi.org/10.1016/j.ajo.2013.02.008
El-Sabagh HA, Abdelghaffar W, Labib AM et al (2011) Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications. Ophthalmology 118:636–641. https://doi.org/10.1016/j.ophtha.2010.08.038
Walshe R, Esser P, Wiedemann P, Heimann K (1992) Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol 76:550–552
Erdurman FC, Pellumbi A, Durukan AH (2012) Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging 43 Online:e87–e89. https://doi.org/10.3928/15428877-20120823-05
Van Geest RJ, Lesnik-Oberstein SY, Tan HS et al (2012) A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 96:587–590. https://doi.org/10.1136/bjophthalmol-2011-301005
Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117:1087–1093.e3. https://doi.org/10.1016/j.ophtha.2009.10.040
Navarrete-Sanchis J, Zarco-Bosquets J, Tomas-Torrent JM et al (2015) Long-term effectiveness of vitrectomy in diabetic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 253:713–719. https://doi.org/10.1007/s00417-014-2745-9
Romano MR, Romano V, Vallejo-Garcia JL et al (2014) MACULAR HYPOTROPHY AFTER INTERNAL LIMITING MEMBRANE REMOVAL FOR DIABETIC MACULAR EDEMA. Retina 34:1182–1189. https://doi.org/10.1097/IAE.0000000000000076
Patel JI, Hykin PG, Schadt M et al (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5–13
Kamura Y, Sato Y, Isomae T, Shimada H (2005) Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol 49:297–300. https://doi.org/10.1007/s10384-005-0199-7
Wolf S, Schnurbusch U, Wiedemann P et al (2004) Peeling of the basal membrane in the human retina: ultrastructural effects. Ophthalmology 111:238–243. https://doi.org/10.1016/j.ophtha.2003.05.022
Pichi F, Lembo A, Morara M et al (2014) Early and late inner retinal changes after inner limiting membrane peeling. Int Ophthalmol 34:437–446. https://doi.org/10.1007/s10792-013-9831-6
Clark A, Balducci N, Pichi F et al (2012) Swelling of the arcuate nerve fiber layer after internal limiting membrane peeling. Retina 32:1608–1613. https://doi.org/10.1097/IAE.0b013e3182437e86
Tadayoni R, Paques M, Massin P et al (2001) Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology 108:2279–2283
Spaide RF (2012) Dissociated optic nerve fiber layer appearance" after internal limiting membrane removal is inner retinal dimpling. Retina 32:1719–1726. https://doi.org/10.1097/IAE.0b013e3182671191
Alkabes M, Salinas C, Vitale L et al (2011) En face optical coherence tomography of inner retinal defects after internal limiting membrane peeling for idiopathic macular hole. Invest Opthalmol Vis Sci 52:8349. https://doi.org/10.1167/iovs.11-8043
Tamura K, Yokoyama T, Ebihara N, Murakami A (2012) Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema. Jpn J Ophthalmol 56:280–287. https://doi.org/10.1007/s10384-012-0130-y
Kenawy N, Wong D, Stappler T et al (2010) Does the presence of an Epiretinal membrane Alter the cleavage plane during internal limiting membrane peeling? Ophthalmology 117:320–323.e1. https://doi.org/10.1016/j.ophtha.2009.07.024
Romano MR, Ilardi G, Ferrara M et al (2018) Intraretinal changes in idiopathic versus diabetic epiretinal membranes after macular peeling. PLoS One 13. https://doi.org/10.1371/journal.pone.0197065
Romano MR, Cennamo G, Montorio D et al (2018) Correlation between various trace elements and ultramicroscopic structure of epiretinal macular membranes and glial cells. PLoS One 13:e0204497. https://doi.org/10.1371/journal.pone.0204497
Das A, McGuire PG, Rangasamy S (2015) Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122:1375–1394. https://doi.org/10.1016/j.ophtha.2015.03.024
Rabbani H, Allingham MJ, Mettu PS et al (2015) Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema. Invest Ophthalmol Vis Sci 56:1482–1492. https://doi.org/10.1167/iovs.14-15457
Spaide RF, Klancnik JM, Cooney MJ (2015) Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 133:45–50. https://doi.org/10.1001/jamaophthalmol.2014.3616
Feng Y, Wang Y, Stock O et al (2009) Vasoregression linked to neuronal damage in the rat with defect of polycystin-2. PLoS One 4:e7328. https://doi.org/10.1371/journal.pone.0007328
Lecleire-Collet A, Audo I, Aout M et al (2011) Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52:2861–2867. https://doi.org/10.1167/iovs.10-5960
Silva KC, Rosales MAB, Biswas SK et al (2009) Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 58:1382–1390. https://doi.org/10.2337/db09-0166
Hammes H-P, Feng Y, Pfister F, Brownlee M (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60:9–16. https://doi.org/10.2337/db10-0454
Yamana Y, Oka Y, Ohnishi Y et al (1988) Reflow of obstructed capillaries in the maculae of humans with diabetic retinopathy, observed by fluorescein angiography. Br J Ophthalmol 72:660–665
Takase N, Nozaki M, Kato A et al (2015) Enlargement of foveal avascular zone in diabetic eyes evaluated by EN face optical coherence tomography angiography. Retina 35:2377–2383. https://doi.org/10.1097/IAE.0000000000000849
Romano MR, Cennamo G, Schiemer S et al (2017) Deep and superficial OCT angiography changes after macular peeling: idiopathic vs diabetic epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 255:681–689. https://doi.org/10.1007/s00417-016-3534-4
Liu L, Wu X, Geng J et al (2012) IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis. PLoS One 7:e44683. https://doi.org/10.1371/journal.pone.0044683
Kim YT, Kang SW, Kim SJ et al (2012) Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results. Graefes Arch Clin Exp Ophthalmol 250:679–684. https://doi.org/10.1007/s00417-011-1888-1
Boyer DS, Faber D, Gupta S et al (2011) Dexamethasone intravitreal implant for treatment of diabetic macular edema in VITRECTOMIZED patients. Retina 31:915–923. https://doi.org/10.1097/IAE.0b013e318206d18c
Acknowledgments
The authors have no proprietary interest in any aspect of this study.
Author information
Authors and Affiliations
Contributions
MRR, DA, MF, CDG, SS contributed to conception and design; MRR, DA, IB, GC to acquisition of data, all authors contributed to interpretation of data; all authors drafted the article and approved its final version.
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have conflict of interest.
Rights and permissions
About this article
Cite this article
Romano, M.R., Allegrini, D., Della Guardia, C. et al. Vitreous and intraretinal macular changes in diabetic macular edema with and without tractional components. Graefes Arch Clin Exp Ophthalmol 257, 1–8 (2019). https://doi.org/10.1007/s00417-018-4173-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-018-4173-8